Asuragen Appoints Lyle Arnold, Ph.D., to Board of Directors

Asuragen, Inc., a leader in molecular diagnostic development, announced today the appointment of Lyle Arnold, Ph.D., to its board of directors.

Dr. Arnold is a veteran biotechnology entrepreneur and a leading developer of novel technologies for the molecular diagnostic industry.

Source: Asuragen